Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.095 USD | -0.43% | -0.67% | -18.54% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.54% | 1.1B | |
+3.94% | 43.43B | |
+47.81% | 41.69B | |
+9.21% | 41.31B | |
-10.92% | 27.14B | |
+8.82% | 25.28B | |
-24.59% | 18.47B | |
+29.46% | 12.59B | |
+1.03% | 12.33B | |
+9.47% | 11.03B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : GlaxoSmithKline's SARS-CoV-2 Antibody Accepted for Rolling Review at European Medicines Agency